4th Quarter - Report
THE SMITH-FREE GROUP, LLC for GVB BIOPHARMA
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Agriculture AGR
H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Discussions relating to regulation of the CBD industry. Monitored discussions relating to regulation of Delta-8 THC. Monitored regulations on hemp/CBD issues. Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK S DEUSER | — |
| MICHAEL A. GAFFIN | — |
| TREVOR W. KOLEGO | — |
Law Enforcement/Crime/Criminal Justice LAW
Monitored H.R. 6129, HOPE Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| TREVOR W. KOLEGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.